GemiFinance
Business

Blood-testing startup Theranos reported to be closing

NEW YORK – The once-heralded blood-testing startup Theranos is shutting down, based on a media report.

Theranos was struggle to sell itself and it’s now hoping to pay unsecured creditors its remaining cash around $5 million while in the upcoming months, depending on a text The Wall Street Journal obtained that CEO David Taylor transported to shareholders.

 
The article you requested is no longer situated on BostonHerald.com.
 
» Click here to evaluate this informative article from the Associated Press’ archive.

Related Articles

Byte of history: Considered one of 1st Apple computers to become sold

Blood-testing startup Theranos supposedly closing

Rare Apple-1 computer, possibly worth $800K-plus, for sale

Related posts

World stocks mixed on worries over trade, manufacturing data

admin

China says its evaluating e-commerce billionaire's US arrest

admin

Suffolk Downs files $1B lawsuit against Wynn Resorts

admin

Leave a Comment

Skip to toolbar